HIRSCHMAN ORIN 13D and 13G filings for Context Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-01-09 5:05 pm Sale | 2023-01-09 | 13G | Context Therapeutics Inc. CNTX | HIRSCHMAN ORIN | 0 0.000% | -1,285,771 (Position Closed) | Filing |
| 2022-10-27 1:22 pm Purchase | 2022-01-06 | 13G | Context Therapeutics Inc. CNTX | HIRSCHMAN ORIN | 1,285,771 8.100% | 1,285,771 (New Position) | Filing |